Internal Medicine · 2019 · 14 citations · 20 references
MedicineBiochemistryGeneticsBone MetabolismHuman GeneticsMedical GeneticsBone DisordersBone Metabolism DisordersDisorders Of Calcium MetabolismDisorders Of Phosphate MetabolismEnzyme DeficienciesPhosphate Homeostasis6-Minute Walk TestBone Enzyme MarkersCalcificationHereditary Hypophosphatemic DisordersMuscle Enzyme DisordersPhosphatasesThoracic DeformityThoracic Spinal Deformity
A 40-year-old Japanese woman presented to our hospital with general fatigue and muscle weakness. She had a history of premature loss of deciduous teeth at 4 years old, her serum alkaline phosphatase (ALP) activity was as low as 91 U/L, and radiologic studies revealed thoracic deformity and sacroiliac calcification. Genetic sequencing revealed a heterozygous c.1559delT mutation in the tissue non-specific alkaline phosphatase gene (ALPL). Based on these findings, she was diagnosed with hypophosphatasia (HPP), and treatment with asfotase alfa, a recombinant human tissue-nonspecific alkaline phosphatase (TNSALP), was initiated. After six months of treatment with asfotase alfa, improvements were observed in the SF-36 score, six-minute walk distance, and grasping power. Although the overdiagnosis needs to be avoided, HPP should be considered in patients with undiagnosed musculoskeletal symptoms and a low serum ALP activity.
20
The MOS 36-ltem Short-Form Health Survey (SF-36)
John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.8K citations
Enzyme-Replacement Therapy in Life-Threatening Hypophosphatasia
Michael P. Whyte, Cheryl R. Greenberg, Nada Salman et al. · New England Journal of Medicine · 2012 · 566 citations · Full text